Form 4: CoreWeave CDO Sells 36,335 Shares via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, sold 36,335 shares of Class A Common Stock across multiple entities on December 15, 2025, through a pre-arranged 10b5-1 trading plan.

Summary

• Brannin McBee, CoreWeave's Chief Development Officer, executed multiple sales of Class A Common Stock on December 15, 2025.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on September 2, 2025.
• A total of 36,335 shares were sold across direct holdings (1,000 shares) and indirect holdings through Canis Major 2025 Family Trust LLC (1,000 shares), Canis Minor 2025 Family Trust LLC (1,000 shares), Canis Major 2025 GRAT (25,000 shares), and Canis Minor 2025 GRAT (8,335 shares).
• The sales occurred at weighted average prices ranging from $72.08 to $79.69 per share.
• This Form 4 represents Part 2 of 3 for the reporting person's transactions, with further transactions expected to be reported.

Sentiment

Score: 5

Explanation: The sale of shares by a Chief Development Officer, while significant in volume, was conducted under a pre-arranged 10b5-1 trading plan, which typically signals a planned liquidity event rather than a reaction to new company-specific information. This makes the event largely neutral in terms of immediate sentiment, though large insider sales can sometimes be viewed with caution.

Positives

• The sales were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, negative company information.

Negatives

• Significant insider selling, totaling 36,335 shares, could be perceived negatively by some investors, even if pre-planned.
• The sales appear to have liquidated the reported beneficial ownership in the specific blocks of shares held directly and indirectly through the mentioned trusts and GRATs.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sales of Class A Common Stock were made indirectly through Canis Major 2025 Family Trust LLC, where the reporting person serves as manager.
• Sales of Class A Common Stock were made indirectly through Canis Minor 2025 Family Trust LLC, where the reporting person serves as manager.
• Sales of Class A Common Stock were made indirectly through Canis Major 2025 GRAT, where the reporting person is the sole trustee and beneficiary.
• Sales of Class A Common Stock were made indirectly through Canis Minor 2025 GRAT, where the reporting person's spouse is the sole beneficiary and trustee.

Stakeholder Impact

• Shareholders: The sale of a significant number of shares by a key executive, even if pre-planned, could lead to a perception of reduced insider confidence or increased supply of shares in the market.

Next Steps

• Additional transactions by the reporting person are expected to be reported in Part 3 of this series of Form 4 filings.

Key Dates

Recommendation

While the sale of a substantial number of shares by a key executive might raise questions, the fact that it was executed under a pre-arranged 10b5-1 trading plan mitigates immediate negative implications. Such plans are typically set up for personal financial planning purposes and do not necessarily reflect a change in the executive's outlook on the company's future performance. Investors should monitor subsequent filings (Part 3) and broader company performance, but this specific filing alone does not warrant a 'sell' recommendation, nor does it provide new positive information for a 'buy.' A 'hold' stance is appropriate, awaiting further operational or financial updates.

Keywords

CoreWeave, CRWV, Brannin McBee, Insider Sale, Form 4, 10b5-1 plan, Chief Development Officer, Stock Sale, Equity Transaction, Beneficial Ownership